Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.58 |
| ▸ | LMNA | P02545 | 3/20 | 0.58 |
| ▸ | CCR1 | P32246 | 3/20 | 0.58 |
| ▸ | CCR5 | P51681 | 3/20 | 0.58 |
| ▸ | CCR8 | P51685 | 3/20 | 0.58 |
| ▸ | MMP2 | P08253 | 2/20 | 0.58 |
| ▸ | TSHR | P16473 | 2/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.58 |
| ▸ | MAPT | P10636 | 2/20 | 0.58 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.58 |
| ▸ | HTT | P42858 | 2/20 | 0.58 |
| ▸ | GMNN | O75496 | 1/20 | 0.58 |
| ▸ | TP53 | P04637 | 1/20 | 0.58 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.58 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.58 |
| ▸ | MMP9 | P14780 | 1/20 | 0.58 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.58 |
| ▸ | MMP8 | P22894 | 1/20 | 0.58 |
| ▸ | THPO | P40225 | 1/20 | 0.58 |
| ▸ | MTOR | P42345 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Oxyquinoline SCHEMBL29460084 | 1.00 | KDM4E (0.58) | KDM4ELMNACCR1CCR5CCR8 | |
| Oxyquinoline SCHEMBL952769 | 0.95 | KDM4E (0.58) | KDM4ELMNACCR1CCR5CCR8 | |
| Oxyquinoline SCHEMBL22660883 | 0.95 | KDM4E (0.58) | KDM4ELMNACCR1CCR5CCR8 | |
| Oxyquinoline SCHEMBL3357860 | 0.95 | KDM4E (0.58) | KDM4ELMNACCR1CCR5CCR8 | |
| Oxyquinoline SCHEMBL23175212 | 0.95 | KDM4E (0.58) | KDM4ELMNACCR1CCR5CCR8 | |
| Oxyquinoline SCHEMBL23091400 | 0.95 | KDM4E (0.58) | KDM4ELMNACCR1CCR5CCR8 | |
| Oxyquinoline SCHEMBL296880 | 0.95 | KDM4E (0.58) | KDM4ELMNACCR1CCR5CCR8 | |
| Oxyquinoline SCHEMBL8537748 | 0.95 | KDM4E (0.58) | KDM4ELMNACCR1CCR5CCR8 | |
| Oxyquinoline SCHEMBL543361 | 0.95 | KDM4E (0.58) | KDM4ELMNACCR1CCR5CCR8 | |
| Oxyquinoline SCHEMBL2873348 | 0.95 | KDM4E (0.58) | KDM4ELMNACCR1CCR5CCR8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 634 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3582778-B1 | COMPOSITIONS OF GALLIUM (III) COMPLEXES FOR ORAL ADMINISTRATION | MEDMELIOR INC (CA) | 2022-10-05 | — | — | EP | claimed |
| US-11213530-B2 | Gallium in the treatment of coronavirus disease | BERNSTEIN LAWRENCE RICHARD (US) | 2022-01-04 | — | — | US | claimed |
| WO-2021258086-A2 | GALLIUM IN THE TREATENT OF CORONAVIRUS DISEASE | BERNSTEIN LAWRENCE (US) | 2021-12-23 | — | — | WO | claimed |
| US-20210275544-A1 | Gallium in the treatment of coronavirus disease | BERNSTEIN LAWRENCE RICHARD (US) | 2021-09-09 | — | — | US | claimed |
| US-10933021-B2 | Compositions of gallium (III) complexes for oral administration | ALTUM PHARMACEUTICALS INC. (CA) | 2021-03-02 | — | — | US | claimed |
| US-20200038334-A1 | COMPOSITIONS OF GALLIUM (III) COMPLEXES FOR ORAL ADMINISTRATION | ALTUM PHARMACEUTICALS INC. (CA) | 2020-02-06 | — | — | US | claimed |
| US-10548849-B2 | Compositions of gallium (III) complexes for oral administration | ALTUM PHARMACEUTICALS INC. (CA) | 2020-02-04 | — | — | US | claimed |
| US-20190262271-A1 | A NANOCOMPLEX | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2019-08-29 | — | — | US | claimed |
| US-20190255100-A1 | TREATMENT OF CARDIOVASCULAR DISEASE BY USING GALLIUM COMPOUNDS TO BIND CALCIFIED LESIONS | LIPIDRISK, LLC | 2019-08-22 | — | — | US | claimed |
| EP-2243177-B1 | PHOSPHORESCENT OLED HAVING DOUBLE HOLE-BLOCKING LAYERS | GLOBAL OLED TECHNOLOGY LLC (US) | 2019-05-15 | — | — | EP | claimed |
| WO-2008036429-A1 | GALLIUM COMPOSITIONS FOR THE TREATMENT OF LIVER CANCER AND METHODS OF USE | BERNSTEIN LAWRENCE R (US) | 2008-03-27 | — | — | WO | claimed |
| WO-2007100382-A2 | ORALLY ADMINISTRABLE GALLIUM COMPOSITIONS AND METHOD OF USE | BERNSTEIN LAWRENCE R (US) | 2007-09-07 | — | — | WO | claimed |
| US-20070098815-A1 | Orally Administrable Gallium Compositions and Methods of Use | BERNSTEIN LAWRENCE R | 2007-05-03 | — | — | US | claimed |
| EP-1694341-A1 | USE OF GALLIUM TO TREAT INFLAMMATORY ARTHRITIS | TITAN PHARMACEUTICALS, INC. (US) | 2006-08-30 | — | — | EP | claimed |
| US-6967062-B2 | White light-emitting OLED device having a blue light-emitting layer doped with an electron-transporting or a hole-transporting material or both | EASTMAN KODAK COMPANY (US) | 2005-11-22 | — | — | US | claimed |
| US-20050220895-A1 | Use of gallium to treat inflammatory arthritis | TITAN PHARMACEUTICALS, INC. | 2005-10-06 | — | — | US | claimed |
| WO-2005058331-A1 | USE OF GALLIUM TO TREAT INFLAMMATORY ARTHRITIS | TITAN PHARMACEUTICALS, INC. (US) | 2005-06-30 | — | — | WO | claimed |
| WO-2005033246-A1 | GREEN ORGANIC LIGHT-EMITTING DIODES | EASTMAN KODAK COMPANY (US) | 2005-04-14 | — | — | WO | claimed |
| US-20050058853-A1 | Green organic light-emitting diodes | EASTMAN KODAK COMPANY | 2005-03-17 | — | — | US | claimed |
| US-20040185300-A1 | White light-emitting OLED device having a blue light-emitting layer doped with an electron-transporting or a hole-transporting material or both | EASTMAN KODAK COMPANY | 2004-09-23 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10548849-B2 | Compositions of gallium (III) complexes for oral administration | COG5, COG3, COG6 | KDM4E 3992/4885LMNA 3709/4885CCR1 2082/4885 |
| US-20200038334-A1 | COMPOSITIONS OF GALLIUM (III) COMPLEXES FOR ORAL ADMINISTRATION | COG5, COG3, COG6 | KDM4E 3992/4885LMNA 3709/4885CCR1 2082/4885 |
| US-10933021-B2 | Compositions of gallium (III) complexes for oral administration | COG5, COG3, COG6 | KDM4E 3992/4885LMNA 3709/4885CCR1 2082/4885 |
| US-20050220895-A1 | Use of gallium to treat inflammatory arthritis | MMP8, CD68, SYVN1 | KDM4E 4707/4885LMNA 4408/4885CCR1 983/4885 |
| US-20190262271-A1 | A NANOCOMPLEX | CD44, MUC1, PROC | KDM4E 3626/4885LMNA 3210/4885CCR1 1638/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.